Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Feasibility Study Contract

14 Dec 2015 14:23

RNS Number : 9876I
Quadrise Fuels International PLC
14 December 2015
 

14 December 2015

 

 

Quadrise Fuels International plc

("QFI", "Quadrise" or the "Company")

 

Feasibility Study Contract

 

 

Quadrise, the emerging supplier of MSAR, a low cost alternative to heavy fuel oil in the shipping, oil refining and power generation markets, is pleased to announce the signing of a first Feasibility Study Contract with a major global corporation that provides technology, consulting, design and construction services to the oil and gas sector.

 

The client aforementioned is developing research into proprietary upgrading technologies for the upstream oil sector jointly with a reputable national oil and gas corporation.

 

A feasibility study contract has been agreed for Quadrise International Limited (QIL) to conduct testing of extra-heavy hydrocarbon residues, at pilot scale, within the Quadrise Research Facility with a defined timetable during the first half of 2016. The value of this contract is expected to be up to £100,000 and is payable entirely by the client.

 

The scope of the study is to establish the feasibility of using MSAR® technology with this proprietary grade of oil residue for the manufacture of stable economic emulsion fuel, with potential applications at the oil-field for steam-raising and power production.

 

Commenting on these developments, Ian Williams, Executive Chairman of QFI, said:

 

"As previously advised, the Company is continually evaluating selective opportunities for MSAR® to be applied in new technology applications. This novel upstream opportunity for MSAR® based steam production or power generation provides another example of where global corporations value the unique expertise of the Quadrise team."

 

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Ian Williams, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

Jason Miles, Chief Operating Officer

 

Nominated Adviser

Smith & Williamson Corporate Finance Limited

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

Broker

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

Alastair Rae

 

Public & Investor Relations

Bell Pottinger

Rollo Crichton-Stuart

+44 (0)20 7861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSBDDCBBBGUS
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.